CELG News 153.26 05/30/2014 04:34:00 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 153.26 $CELG

Biogen Idec
at Investor's Business Daily - Thu May 29, 5:48PM CDT
Biogen Idec (BIIB) rose 4% after JPMorgan upgraded its stock to overweight from neutral, citing positive opinions on oral multiple-sclerosis drug Tecfidera, and hiked its price target to 375 from 300. JPMorgan cut Celgene (CELG) to neutral from...

Scorned Pfizer Should Forget AstraZeneca and Buy Celgene Instead
Todd Campbell, The Motley Fool - Motley Fool - Thu May 29, 5:30PM CDT
AstraZeneca played hard to get and won, at least for now. The British pharmaceutical major this month rejected two nine-figure buyout offers from   Pfizer , which now must wait at least three months before making  any additional offers. ...

Array BioPharma Collaborates with Biogen - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 29, 4:10PM CDT
Array BioPharma (ARRY) announced that it has entered into a drug discovery collaboration agreement with Biogen Idec (BIIB).

Biogen Upgraded, Celgene Downgraded On Pipelines
at Investor's Business Daily - Thu May 29, 2:18PM CDT
Big-cap biotechs Biogen Idec (BIIB) and Celgene (CELG) were headed in opposite directions on the stock market today after JPMorgan upgraded one and downgraded the other. JPMorgan analyst Geoff Meacham lifted his rating on Biogen to overweight from...

Midday Glance: Biotechnology companies
AP - Thu May 29, 12:25PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

Early Glance: Biotechnology companies
AP - Thu May 29, 9:51AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Stocks Slightly Higher Amid Mixed Data; S&P 500 Logs New High
at Investor's Business Daily - Thu May 29, 9:32AM CDT
Stocks opened modestly higher Thursday despite mixed economic data. The Nasdaq climbed 0.4% to its best levels since early April. The S&P 500 rose 0.2% to a record high. Meanwhile, the Dow Jones industrial average ticked up 0.1%. Volume was tracking...

Veracyte, Foundation Medicine and Panacea Global Paving Way in Faster, More Accurate Cancer Diagnostics
ACCESSWIRE - Thu May 29, 8:53AM CDT
Whitefish, MT / May 29, 2014 / Most of the science behind disease is only truly understandable by scientists, researchers, and physicians rather than the general population. What everyone does understand is that, in virtually every scenario, early detection is a key to treatment or even survivorship. The life sciences IPO boom that started in 2013 has created some additional wind under the sails of few diagnostics companies, including Veracyte Inc. (NASDAQ: VCYT) and Foundation Medicine Inc. (NASDAQ: FMI), and it should have investors taking a closer look at upstart Panacea Global, Inc. (OTCQB: PANG) and its new cancer-detecting technology.

How Will Celgene (CELG) Stock Be Affected By This Analyst Action?
at The Street - Thu May 29, 7:17AM CDT
Shares of Celgene (CELG) are lower after J.P. Morgan (JPM) downgraded the stock to 'neutral' from 'overweight' and lowered its price target to $170. from $180.

Breakthrough Innovation for Animal Health, Upcoming Conference Presentations, and New Treatment Options for Patients - Analyst Notes on Merck, Actavis, Celgene, Bristol-Myers Squibb and GSK
PR Newswire - Thu May 29, 4:50AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Actavis plc (NYSE: ACT), Celgene Corporation (NASDAQ: CELG), Bristol-Myers Squibb Co. (NYSE: BMY) and GlaxoSmithKline plc (NYSE: GSK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3057-100free.

Final Glance: Biotechnology companies
AP - Wed May 28, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:

Cramer: A Market Too Stupid for Words
at The Street - Wed May 28, 10:32AM CDT
It is pretty incredible that identical news can trigger completely different reactions.

After Yesterday's Rally of 3.33% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue May 27, 3:50PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $150.01 to a high of $155.24. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $151.78 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Celgene Rises 3.33% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue May 27, 3:49PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $150.01 to a high of $155.24. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $151.78 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 Health Care Stocks Nudging The Sector Higher
at The Street - Tue May 27, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.

2014 Value Investor 500: The Full List
Dan Dzombak, The Motley Fool - Motley Fool - Sat May 24, 8:01AM CDT
The Value Investor 500 is my attempt to highlight the top 500 publicly traded companies in the U.S. To construct a quality-based list of the top 500 companies in the U.S., I focused on what's really important for investors to pay attention to: ...

How Will Biotech Fare the Rest of the Year?
George Budwell, The Motley Fool - Motley Fool - Fri May 23, 5:30PM CDT
Biotech has had a fairly volatile year thus far. Shares of the closely watched iShares Nasdaq Biotech Index , for instance, have swung from double-digit gains to high single-digit losses at one point this year. With the index now roughly flat for...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Oman’s Dhofar II Wind Deal Clears Financing Hurdle

Updated Category News Views 127

Dhofar’s next wind farm has crossed the line that matters: financial close. That is less glamorous than turbines spinning against an Omani skyline, but it is the point where a project stops being an attractive deck and becomes a real contractual obligation. Sembcorp Utilities, alongside OQ Alternative Energy through Naseem Dhofar SAOC, has brought the 125-megawatt...

Continue Reading
Cloud Optical Demand Is Running Ahead of Supply in 2026

Updated Category News Views 51

Fiber capacity has become the awkward bottleneck nobody can wish away. Dell’Oro Group says the optical transport equipment market expanded 24% year over year in the third quarter of 2026, with large North American cloud providers doing the heavy lifting. More pointedly, optical vendor revenue tied to those cloud customers jumped 75%. That is not a gentle improvement in...

Continue Reading
PayPal Adds a Risk Hand to Its Board at a Crucial Turn

Updated Category News Views 91

A Boardroom Hire With Some Actual Weight PayPal did not go hunting for another decorative résumé. Brian J. Lee, set to join the board on November 30, 2026, spent decades inside Goldman Sachs, including a stint as chief risk officer from 2019 through January 2025. For a payments company trying to sharpen its financial-services identity, that is a serious piece of...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 247

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 94

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 65

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 96

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 72

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 105

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 112

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading

Top 5 Most Recently Viewed Articles

BGSF Stock Declines as Company Reassesses Market Strategies

Updated Category News Views 181

BGSF Faces Market Headwinds as Stock Hits 52-Week Low In the midst of a tough market landscape, BG Staffing Inc (NYSE: BGSF) has seen its stock hit a 52-week low, dropping to $5.13. This decline mirrors a significant reduction in share value, with a notable 44.7% decrease over the past year. The current economic climate has prompted a cautious approach among investors,...

Continue Reading
Datadog's Earnings Predictions and Market Outlook for 2025

Updated Category News Views 254

What to Expect from Datadog's Earnings Announcement Datadog (NASDAQ: DDOG) is gearing up to announce its latest quarterly earnings, generating considerable interest among investors. Understanding the key metrics and expectations surrounding this event can be crucial for those looking to navigate the market effectively. Analysts' Expectations for Earnings Analysts...

Continue Reading
Investors Can Join Metagenomi, Inc. Securities Class Action

Updated Category News Views 245

Understanding Opportunities for Metagenomi, Inc. Investors Investing in stocks, especially during an initial public offering (IPO), carries risks, but it also presents unique opportunities. If you have purchased shares of Metagenomi, Inc. (NASDAQ: MGX), you might be eligible for compensation as part of a class action lawsuit. This opportunity has been highlighted by...

Continue Reading
Recent Market Trends and Insights on MongoDB Options Movements

Updated Category News Views 139

A Deep Dive into MongoDB's Options Activity Recently, attention has shifted towards MongoDB (NASDAQ: MDB), as financial giants display significant bearish moves that have piqued the interest of traders and analysts alike. An examination of MongoDB's options activity has unveiled a notable pattern, indicating varied sentiments in the market. In the latest analysis, we...

Continue Reading
Sotherly Hotels Inc. Revises Dividend Tax Treatment Details

Updated Category News Views 112

Understanding Recent Changes in Dividend Tax Treatment Sotherly Hotels Inc. (NASDAQ: SOHO), a notable player in the lodging industry, has recently announced amendments regarding the estimated income tax classification for its 2024 distributions related to the Series D preferred shares. This revision, first mentioned on February 18, arises from inaccuracies found in the...

Continue Reading